Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Visx' Star

This article was originally published in The Gray Sheet

Executive Summary

Visx' Star: Excimer laser is approved via PMA supplement for treatment of moderate-to-severe myopia between -6 and -12 diopters with up to -4 diopters of concomitant myopic astigmatism, the firm reports Jan. 29. The system was previously approved for myopia up to -6 diopters with myopic astigmatism of up to -4 diopters. "Greater than 99% of nearsighted consumers, with or without astigmatism, are now eligible for laser vision correction" with the device, the firm claims. The firm plans to file for approval of hyperopia treatment in the first quarter...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel